Azenta: Investor Insights and Opportunities for Growth

Recent News

Dec 29, 2025

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.À R.L., for a...

Dec 10, 2025

Azenta Authorizes $250 Million Share Repurchase Program

Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common...

Nov 21, 2025

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

Q4'25 reported revenue growth of 6% year over year and 4% on an organic basis FY'25 reported revenue growth of 4% and 3% on an organic basis FY'25 Adjusted EBITDA margin expansion of 310 basis...

All Releases

Featured Events

Azenta Life Sciences Investor Day

Wed, Dec 10, 2025

1:00pm EST

Invite Only Event

Azenta Q4'25 Earnings Release Conference Call and Webcast

Fri, Nov 21, 2025

8:30am - 9:30am EST

LEARN MORE ABOUT
AZENTA LIFE SCIENCES